3 completed, 1 terminated. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Ginkgo biloba: new trials by email Literature Review of Ginkgo biloba trials Research Report on Ginkgo biloba
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents Ginkgo biloba - Vitiligo Vulgaris | Phase 1 | Completed | University of Toronto | 12 | 2009-05-01 | 2010-07-08 |
| Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT) ginkgo biloba, matched placebo - Memory, Short-Term | Phase 1 / Phase 2 | Terminated | Medical University of South Carolina | 50 | 2003-02-01 | 2018-07-18 |
| Effect of Ginkgo Biloba on Phenytoin Elimination Ginkgo Biloba - Healthy | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 12 | 2001-02-01 | 2008-03-04 |
| Natural Antioxidants in the Treatment of Multiple Sclerosis Ginkgo biloba, Alpha-lipoic acid, Vitamin E/Selenium - Multiple Sclerosis | Phase 1 / Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 1999-09-01 | 2006-08-18 |
Multiple Sclerosis (1) · Vitiligo (1)
Medical University of South Carolina (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · National Institutes of Health Clinical Center (CC) (1) · University of Toronto (1)
United States (3) · Canada (1)
Charles H. Kellner, M.D. (1) · Dr. Dennis Bourdette (1) · Heather Boon, PhD (1) · John S. Markowitz, PharmD (1) · Orest Szczurko, ND MSc(cand) (1) · Thomas W Uhde, MD (1)
P50AT000066 (1), R21AT000939 (1)